Owing to its intricate pathophysiology, cerebral stroke is a serious medical condition caused
by interruption or obstruction of blood supply (blockage of vasculature) to the brain tissues …

Objective: Patients experiencing acute ischemic stroke or transient ischemic attack are
commonly treated with clopidogrel and/or aspirin (mono-and dual-antiplatelet therapy) to …

Objective: To investigate the safety and efficacy of short-term (7-day) Dual Antiplatelet
Therapy (DAPT) with intensive rosuvastatin in Acute Ischemic Stroke (AIS). Methods: In this …

Objectives The current study compared the safety and efficacy of long-term dual antiplatelet
therapy (DAPT, aspirin plus clopidogrel) and intensive rosuvastatin with short-term DAPT for …

Background and objective Stroke is a leading cause of disability and death globally. Dual
antiplatelet therapy (DAPT) with clopidogrel and aspirin is a common intervention for acute …

目的: 探讨3 种不同抗血小板方案治疗轻型急性缺血性脑卒中(acuteischemicstroke, AIS)
的安全性和有效性, 以便对AIS 进行更精准的抗血小板治疗. 方法: 登记2017 年1 月1 日—2019 …

的终身卒中风险(39.3%) 在同项比较中仍居于世界首位[1], 因此我国卒中防治工作任重而道远.
选择合理的个体化治疗方案, 有效地改善侧支循环, 减轻卒中后的脑损伤仍是今后临床工作的 …

A sensitive and specific high‐performance liquid chromatography–tandem mass
spectrometry method has been developed to determine the pharmacokinetic interactions of …

Es claro el papel contundente de la terapia antiplaquetaria dual en la reducción de eventos
cardiovasculares adversos mayores recurrentes en los pacientes con síndrome coronario …

It is clear a strong role of dual antiplatelet therapy in reducing recurrent major adverse
cardiovascular events in patients with acute and chronic coronary syndrome, with a …